Beherasco, Aida F.

HRN: 21-30-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2022
CEFUROXIME 1.5GM (VIAL)
05/06/2022
05/06/2022
IV
1.5g
Once
For TAhbs
Waiting Final Action 
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/08/2022
IV
750mg
3 Doses
S/P TAHBSO
Waiting Final Action 
05/08/2022
CEFUROXIME 500MG (TAB)
05/08/2022
05/14/2022
ORAL
500mg/tab
BID
S/P TAHBSO/
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: